PRIA Logo™
OklahomaHB 2048Oklahoma 2026 Regular SessionHouse

Prescriptions; 340B Nondiscrimination Act; definitions; discriminatory actions; reimbursement; manufacturer; distributor; enforcement; Attorney General; Insurance Commissioner; violations; federal preemption; effective date.

Sponsored By: Preston Stinson (Republican)

Became Law

Senate Committee

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

3 provisions identified: 3 benefits, 0 costs, 0 mixed.

State enforces discounted drug access protections

Beginning November 1, 2025, the Oklahoma Insurance Department enforces the 340B protections against health insurers. The Attorney General enforces them against other covered people and businesses outside the department’s enforcement authority. Each prohibited act counts separately and can bring a civil fine of $100 to $10,000. Both agencies can issue rules to carry out the law.

Fairer pharmacy payments and patient choice

Beginning November 1, 2025, Oklahoma protects providers and pharmacies in the federal 340B drug discount program. Insurers, pharmacy benefit managers, and other payors cannot cut payments or impose worse terms because of 340B participation. This includes special fees, lower dispensing payments, different audits, network limits, and demands for 340B cost or pricing data. Patients cannot face extra charges, copayment changes, or limits on pharmacy choice because they choose a 340B provider. Pharmacy benefit managers also cannot base drug coverage or covered-drug lists on 340B status. Their 340B claims become final when the payment decision is made; ordinary claim corrections unrelated to 340B pricing remain allowed. Oklahoma Medicaid has an exception for covered outpatient drug payments, and its claims are exempt from the special billing-code restriction. Information needed to run Medicaid under federal or state requirements can still be required.

Protected drug access through local pharmacies

Beginning November 1, 2025, manufacturers cannot block 340B providers from buying or receiving drugs through the federal discount program. They also cannot interfere with those providers’ contracted pharmacies. The drug-access rule has an exception when the U.S. Department of Health and Human Services prohibits receipt. A 340B provider must contract with any willing pharmacy within 15 miles when both sides agree on terms. There is no cap on the number of contracted pharmacies.

Sponsors & Cosponsors

Sponsor

  • Preston Stinson

    Republican • House

Cosponsors

  • Nick Archer

    Republican • House

  • Jared Deck

    Democratic • House

  • Ellyn Hefner

    Democratic • House

  • Brent Howard

    Republican • Senate

  • Anthony Moore

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 381 • No: 35

House vote • 5/29/2025

OVERRIDE

Yes: 79 • No: 9

Senate vote • 5/29/2025

OVERRIDE

Yes: 42 • No: 3

Senate vote • 5/8/2025

THIRD READING

Yes: 40 • No: 5

Senate vote • 4/23/2025

Committee vote: Appropriations

Yes: 22 • No: 1

Senate vote • 4/14/2025

Committee vote: Health & Human Services

Yes: 12 • No: 1

House vote • 3/26/2025

THIRD READING

Yes: 82 • No: 8

House vote • 3/26/2025

THIRD READING

Yes: 83 • No: 8

House vote • 3/6/2025

DO PASS

Yes: 13 • No: 0

House vote • 2/13/2025

DO PASS

Yes: 8 • No: 0

Actions Timeline

  1. Filed with Secretary of State

    5/29/2025House

  2. Measure returned to House

    5/29/2025Senate

  3. Veto overridden: Ayes: 42 Nays: 3

    5/29/2025Senate

  4. To Senate

    5/29/2025House

  5. Veto overridden: Ayes: 79 Nays: 9

    5/29/2025House

  6. Vetoed 05/17/2025

    5/19/2025House

  7. Sent to Governor

    5/12/2025House

  8. Enrolled measure signed, returned to House

    5/12/2025Senate

  9. Enrolled, signed, to Senate

    5/12/2025House

  10. Referred for enrollment

    5/8/2025House

  11. Engrossed measure signed, returned to House

    5/8/2025Senate

  12. Measure passed: Ayes: 40 Nays: 5

    5/8/2025Senate

  13. Amendment restored bill to engrossed version

    5/8/2025Senate

  14. Title restored

    5/8/2025Senate

  15. General Order, Amended

    5/8/2025Senate

  16. Placed on General Order

    4/28/2025Senate

  17. Reported Do Pass Appropriations committee; CR filed

    4/23/2025Senate

  18. Referred to Appropriations

    4/14/2025Senate

  19. Title stricken

    4/14/2025Senate

  20. Reported Do Pass as amended Health and Human Services committee; CR filed

    4/14/2025Senate

  21. Second Reading referred to Health and Human Services Committee then to Appropriations Committee

    4/1/2025Senate

  22. First Reading

    3/27/2025Senate

  23. Engrossed, signed, to Senate

    3/27/2025House

  24. Referred for engrossment

    3/26/2025House

  25. Third Reading, Measure passed: Ayes: 83 Nays: 8

    3/26/2025House

Bill Text

  • Enrolled (final version)

    5/12/2025

    PDF

  • Floor (Senate)

    4/24/2025

    PDF

  • Senate Committee Report 2

    4/23/2025

    PDF

  • Senate Committee Report 1

    4/14/2025

    PDF

  • Engrossed

    3/27/2025

    PDF

  • Floor (House)

    3/9/2025

    PDF

  • House Committee Report

    3/6/2025

    PDF

  • House Policy Committee Report

    2/20/2025

    PDF

  • Introduced

    1/16/2025

    PDF

Related Bills

Back to State Legislation